...
首页> 外文期刊>Journal of Diabetes Science and Technology >Effects of Simulated Altitude on Blood Glucose Meter Performance: Implications for In-Flight Blood Glucose Monitoring
【24h】

Effects of Simulated Altitude on Blood Glucose Meter Performance: Implications for In-Flight Blood Glucose Monitoring

机译:模拟海拔高度对血糖仪性能的影响:对飞行中血糖监测的意义

获取原文
           

摘要

Background: Most manufacturers of blood glucose monitoring equipment do not give advice regarding the use of their meters and strips onboard aircraft, and some airlines have blood glucose testing equipment in the aircraft cabin medical bag. Previous studies using older blood glucose meters (BGMs) have shown conflicting results on the performance of both glucose oxidase (GOX)- and glucose dehydrogenase (GDH)-based meters at high altitude. The aim of our study was to evaluate the performance of four new-generation BGMs at sea level and at a simulated altitude equivalent to that used in the cabin of commercial aircrafts. Methodology/Principal Findings: Blood glucose measurements obtained by two GDH and two GOX BGMs at sea level and simulated altitude of 8000 feet in a hypobaric chamber were compared with measurements obtained using a YSI 2300 blood glucose analyzer as a reference method. Spiked venous blood samples of three different glucose levels were used. The accuracy of each meter was determined by calculating percentage error of each meter compared with the YSI reference and was also assessed against standard International Organization for Standardization (ISO) criteria. Clinical accuracy was evaluated using the consensus error grid method. The percentage (standard deviation) error for GDH meters at sea level and altitude was 13.36% (8.83%; for meter 1) and 12.97% (8.03%; for meter 2) with p = .784, and for GOX meters was 5.88% (7.35%; for meter 3) and 7.38% (6.20%; for meter 4) with p = .187.There was variation in the number of time individual meters met the standard ISO criteria ranging from 72–100%. Results from all four meters at both sea level and simulated altitude fell within zones A and B of the consensus error grid, using YSI as the reference. Conclusions: Overall, at simulated altitude, no differences were observed between the performance of GDH and GOX meters. Overestimation of blood glucose concentration was seen among individual meters evaluated, but none of the results obtained would have resulted in dangerous failure to detect and treat blood glucose errors or in giving treatment that was actually contradictory to that required.
机译:背景:大多数血糖监测设备制造商并未就其在飞机上使用仪表和带的使用提供建议,并且一些航空公司在机舱医疗袋中配备了血糖测试设备。以前使用较老的血糖仪(BGM)进行的研究表明,在高海拔地区,基于葡萄糖氧化酶(GOX)和基于葡萄糖脱氢酶(GDH)的血糖仪的性能存在矛盾。我们的研究目的是评估四种新一代BGM在海平面和模拟高度(与商用飞机机舱中使用的高度相同)下的性能。方法/主要发现:将两个GDH和两个GOX BGM在海平面和低压舱中的模拟高度8000英尺处获得的血糖测量值与使用YSI 2300血糖分析仪作为参考方法获得的测量值进行比较。使用了三种不同葡萄糖水平的尖刺静脉血样品。每个仪表的精度是通过计算每个仪表与YSI参考的百分比误差来确定的,并且还根据国际标准化组织(ISO)的标准进行了评估。使用共识误差网格法评估临床准确性。 GDH仪表在海平面和高度上的百分比(标准偏差)误差为13.36%(8.83%;对于仪表1)和12.97%(8.03%;对于仪表2),p = .784,对于GOX仪表为5.88% (7.35%;对于仪表3)和7.38%(6.20%;对于仪表4),p = .187。各个仪表达到标准ISO标准的时间范围在72%至100%之间变化。使用YSI作为参考,在海平面和模拟高度上所有四米的结果都落在共识误差网格的A和B区域内。结论:总的来说,在模拟高度下,GDH和GOX仪表的性能没有差异。在所评估的各个仪表中,血糖浓度被高估了,但是所获得的任何结果都不会导致危险的无法检测和治疗血糖错误,或导致与要求的治疗实际上矛盾的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号